Lifeward (LFWD) Non-Current Deffered Revenue (2014 - 2026)
Lifeward's (LFWD) quarterly Non-Current Deffered Revenue came in at $1.2 million in Q1 2026, up 2.98% year-on-year from $1.2 million in Q1 2025, and down 2.03% quarter-over-quarter from $1.2 million in Q4 2025.
Lifeward (LFWD) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends
Lifeward has disclosed Non-Current Deffered Revenue across 13 years of filings, most recently posting $1.2 million for Q1 2026.
- Non-Current Deffered Revenue for Q1 2026 came in at $1.2 million, up 2.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2.98% YoY), and the FY2025 annual result was $1.2 million, down 6.87% from the prior year.
- Non-Current Deffered Revenue came in at $1.2 million for Q1 2026 at Lifeward, down from $1.2 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $1.6 million in Q3 2023 to a low of $808000.0 in Q3 2022.
- The 5-year median for Non-Current Deffered Revenue is $1.2 million (2026), against an average of $1.1 million.
- Across the five-year window, Non-Current Deffered Revenue surged 103.59% in 2023 and slipped 20.91% in 2024, its largest moves.
- Lifeward's Non-Current Deffered Revenue stood at $890000.0 in 2022, then soared by 69.21% to $1.5 million in 2023, then fell by 12.08% to $1.3 million in 2024, then slipped by 6.87% to $1.2 million in 2025, then decreased by 2.03% to $1.2 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $1.2 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Lifeward | 11.14 Mn | -263,371.13 | 1.34 Mn | 1.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.21 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.17 Mn |
| Dec 31, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 841,000.00 |
| Mar 31, 2023 | 895,000.00 |
| Dec 31, 2022 | 890,000.00 |
| Sep 30, 2022 | 808,000.00 |
| Jun 30, 2022 | 810,000.00 |
| Mar 31, 2022 | 825,000.00 |
| Dec 31, 2021 | 866,000.00 |
| Sep 30, 2021 | 763,000.00 |
| Jun 30, 2021 | 727,000.00 |